Journal
JOURNAL OF NEUROSCIENCE
Volume 35, Issue 8, Pages 3330-3345Publisher
SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.1574-14.2015
Keywords
astrocytes; astrogliosis; bumetanide; EEG; epilepsy; seizures
Categories
Funding
- National Institutes of Health (NIH) [2RO1NS036692, 5RO1NS031234, 5R01NS052634, 1F31NS074597, 1R01NS082851]
- German Research Foundation
- Epilepsy Foundation
- American Brain Tumor Association
- National Institutes of Health Eunice Kennedy Shriver Intellectual and Developmental Disabilities [5P30HD038985]
Ask authors/readers for more resources
Epilepsy is one of the most common chronic neurologic diseases, yet approximately one-third of affected patients do not respond to anticonvulsive drugs that target neurons or neuronal circuits. Reactive astrocytes are commonly found in putative epileptic foci and have been hypothesized to be disease contributors because they lose essential homeostatic capabilities. However, since brain pathology induces astrocytes to become reactive, it is difficult to distinguish whether astrogliosis is a cause or a consequence of epileptogenesis. We now present a mouse model of genetically induced, widespread chronic astrogliosis after conditional deletion of beta 1-integrin (Itg beta 1). In these mice, astrogliosis occurs in the absence of other pathologies and without BBB breach or significant inflammation. Electroencephalography with simultaneous video recording revealed that these mice develop spontaneous seizures during the first six postnatal weeks of life and brain slices show neuronal hyperexcitability. This was not observed in mice with neuronal-targeted beta 1-integrin deletion, supporting the hypothesis that astrogliosis is sufficient to induce epileptic seizures. Whole-cell patch-clamp recordings from astrocytes further suggest that the heightened excitability was associated with impaired astrocytic glutamate uptake. Moreover, the relative expression of the cation-chloride cotransporters (CCC) NKCC1 (Slc12a2) and KCC2 (Slc12a5), which are responsible for establishing the neuronal Cl- gradient that governs GABAergic inhibition were altered and the NKCC1 inhibitor bumetanide eliminated seizures in a subgroup of mice. These data suggest that a shift in the relative expression of neuronal NKCC1 and KCC2, similar to that observed in immature neurons during development, may contribute to astrogliosis-associated seizures.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available